Introduction
Traditionally, medical device safety was defined by biocompatibility and mechanical reliability. Today, safety is inextricably linked to cybersecurity. A device that can be hacked is, by definition, unsafe.
A Secure SDLC is a framework that integrates security activities—such as threat modeling, code analysis, and vulnerability testing—into every phase of the development process. For MedTech companies, this is no longer just a best practice; it is a regulatory mandate required to avoid “Refuse to Accept” (RTA) decisions from the FDA.
“Shift-Left” Security: Designing for Defense
The “Shift-Left” philosophy dictates that security must begin during the requirements gathering phase, not during final testing.
- Security Requirements: Define what the system must not do. For example: “The device shall only accept encrypted firmware updates from authenticated sources.”
- Architecture Review: Designing for isolation. If a device has a Bluetooth interface for patient data and a cellular interface for cloud sync, the Secure SDLC ensures these pathways are segmented so a breach in one doesn’t compromise the other.
Threat Modeling: The “What-If” Analysis
Before a single line of code is written, MedTech teams must conduct Threat Modeling. This is a structured exercise to identify potential attack vectors based on the device’s intended use and environment.
Common frameworks like STRIDE (Spoofing, Tampering, Information Disclosure, etc.) are used to ask:
- Can an unauthorized user spoof the doctor’s identity?
- Can the dosage commands be tampered with in transit?
- Is there a “backdoor” in the diagnostic port?
By identifying these threats early, mitigations become part of the design inputs, rather than expensive retrofits after a failed penetration test.
The SBOM (Software Bill of Materials): Essential Transparency
In 2026, the Software Bill of Materials (SBOM) has become the most critical document in the Vulnerability Management arsenal. An SBOM is a nested list of ingredients—every library, open-source component, and third-party driver used in your software.
- Why it matters: When a new vulnerability (like a future Log4j) is discovered, the SBOM allows a manufacturer to know within seconds if their devices are affected.
- FDA Requirements: The FDA now requires a robust SBOM for pre-market submissions. A MedTech Secure SDLC must include an automated process to generate and update this list as the software evolves.
Secure Coding and Automated Analysis (SAST & DAST)
To prevent common vulnerabilities like buffer overflows or injection flaws, developers must adhere to standards like CERT or MISRA. The Secure SDLC automates the enforcement of these standards:
- Static Application Security Testing (SAST): Scans the source code for vulnerabilities without executing it. It’s like a spell-check for security flaws.
- Dynamic Application Security Testing (DAST): Tests the application while it is running, simulating an external attacker to find “blind spots” in the implementation.
- Software Composition Analysis (SCA): Specifically checks your SBOM against databases of known vulnerabilities (CVEs).
Post-Market Vulnerability Management
A medical device’s security life begins at launch. A MedTech Cybersecurity strategy must include a formal plan for Patch Management.
- Coordinated Vulnerability Disclosure (CVD): A process for researchers to report flaws to the manufacturer without them being made public immediately.
- Patch Deployment: How will the device be updated? Over-the-air (OTA) updates are efficient but require their own Secure SDLC to ensure the update mechanism itself isn’t a vulnerability.
Visure’s Role: Orchestrating the Secure SDLC
Managing cybersecurity across thousands of requirements and code commits is impossible with spreadsheets. Visure Requirements ALM serves as the “Security Command Center”:
- Threat-to-Requirement Mapping: Link identified threats directly to the requirements designed to mitigate them. If a requirement changes, Visure alerts you to the potential security gap.
- SBOM Integration: Maintain your Software Bill of Materials within the platform, linking every third-party component to its version and security status.
- Vulnerability Traceability: Track discovered vulnerabilities (from pentests or scans) directly to the affected design components and their eventual fixes.
- Compliance Reporting: Automatically generate the cybersecurity documentation required for FDA and EU MDR submissions, including the Threat Model and Mitigation Evidence.
- Vivia AI: Use Vivia to scan your security requirements for “completeness,” ensuring that common cybersecurity pitfalls aren’t overlooked during the design phase.
Conclusion
A Secure SDLC is not a destination; it is a continuous commitment to patient safety. In the modern MedTech landscape, clinical efficacy is useless if the device cannot be trusted to operate without interference.
By integrating Threat Modeling, maintaining a transparent SBOM, and leveraging automated analysis tools, manufacturers can build devices that are “Secure by Design.” In 2026, the most successful companies are those that treat cybersecurity not as a regulatory hurdle, but as a foundational brand promise to the patients they serve.
Check out the free trial at Visure and experience how AI-driven change control can help you manage changes faster, safer, and with full audit readiness.
